Department: Medicine

Biophysical control of cardiovascular development, pluripotent stem cell biology, optogenetics, electrophysiology, cell mechanics, directed cellular evolution, multiscale engineering, microfluidics, computational biology

Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies. The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.

Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system

My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models. I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma.

I am interested in identifying targeted therapies for triple-negative breast cancers and developing a novel strategy of biomarker-based chemoprevention for hereditary cancers that arise due to mutations in the Breast Cancer Susceptibility Gene 1 (BRCA1).

I refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/

The ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders DIABETES The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes. (1) Beta-Cel..

Research interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.

Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function and genomic stability. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.

Health services research, Quality assessement, Quality improvement, Implementation science, Health sevices to improve value of care, HIV, HCV, Cancer, Palliative care, Renal disease

The Ashley lab is focused on the application of genomics to medicine. We develop methods for the interpretation of whole genome sequencing data to improve diagnosis of genetic disease and to personalize the practice of medicine. We also use RNA sequencing data to generate gene networks and link communities. Half of the lab is wet benches where we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality of our favorite targets.

Genetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Pharmacoepidemiology of Cardiovascular Drugs & Outcomes, Cardiovascular Medicine related Pharmacogenomics, Biomarkers to predict major adverse cardiovascular events, Determinants of Insulin Mediated Glucose Uptake in South Asians

Development and implementation of rapid diagnostic assays for the detection, identification, and susceptibility testing of clinically important mycobacteria. Understanding the role of M. tuberculosis lipoproteins in the pathogenesis of tuberculosis.

Prevention and treatment of obesity; promotion of physical activity and healthful eating; neighborhood determinants of health; the role of community parks in promoting physical activity; environmental and policy interventions.

Dr. Banerjee is the Director of Endoscopy at the Stanford University Medical Center. His research interests include evaluation of advanced endoscopic procedures (ERCP, choledochoscopy and endoscopic ultrasound) in the diagnosis and management of benign and malignant pancreatic and biliary disease. Additional interests include the development of new endoscopic devices and instruments.

My current research interests include: 1. Improving outcomes in patients with left ventricular assist devices (LVAD) 2. implementing protocols to improve heart failure outcomes (PI on Gordon & Betty Moore Foundation grant for implementation of a transitional care program at Stanford for heart failure patients) 3. Investigating the relationship between insulin resistance and heart failure 4. Exploring racial/ethnic disparities in cardiovascular disease

Yale /Stanford / Johnson and Johnson Global Scholars Program 7 /2002 – 7/2009 Funds 50 – 60 physicians overseas to underserved clinical sites in South America, Africa and Asia for educational and capacity infrastructure building. Role: Co-director and Founder of program $3.5 million Area of research Ethical Aspects of research conducted overseas Clinical Tropical Diseases Globalization's Impact upon Health

Medical education, preparation for clerkship curricula and hospital medicine.

Type I and type II diabetes, insulin pump therapy, glucose sensor technology, insulin resistance, PCOS, thyroid disorders

mathematical models econometrics global health social determinants of health health policy

Effect of global health policies on health of individuals in developing countries, global health, HIV and TB.

My research interests adoptive transfer of defined subsets of lymphocytes for the treatment of hematologic malignancies. I have a specific interest in the treatment of Myelodysplastic Syndromes with non-myeloablative and reduced intensity transplant conditioning regimens.

My main focus of interest is in bedside echocardiography. I am working on expanding the use of goal-directed echocardiography to non-cardiologists: intensivists, emergency physicians and internal medicine physicians. I have created a specific training program including didactic lectures with a supporting website, a scanning learning method and a standardized evaluation of proficiency in bedside ultrasound.

Dr. Bhalla's research interests are in the pathogenesis of diabetic kidney disease and salt-sensitive hypertension. Using molecular and transgenic approaches, the laboratory is interested in elucidating regulators of oxidative and carbonyl stress in glomeruli. We interface these studies with collaborative projects on biomarkers for human diabetic nephropathy. The laboratory also focuses on molecular mechanisms of insulin and aldosterone-induced sodium transport in the distal nephron.

My research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.

My interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya

Clinical pharmacology of antiretroviral drugs Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response. Drug development